跳轉至內容
Merck
  • Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.

Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.

Antimicrobial agents and chemotherapy (2010-04-14)
A Morvan, C Moubareck, A Leclercq, M Hervé-Bazin, S Bremont, M Lecuit, P Courvalin, A Le Monnier
摘要

Susceptibility to antibiotics of 4,816 clinical L. monocytogenes strains isolated since 1926 was studied, and the temporal evolution of susceptibility to antibiotics was analyzed through several decades. The mechanisms of resistance in each resistant strain were studied. The prevalence of resistant strains was estimated at 1.27% among isolates from humans. Resistance to tetracyclines+ and fluoroquinolones was more common and has recently emerged. Although acquired resistance in clinical L. monocytogenes did not implicate clinically relevant antibiotics, the possibility of resistance gene transfers, the description of the first clinical isolate with high-level resistance to trimethoprim, and the recent increase in penicillin MICs up to 2 microg/ml reinforce the need for microbiological surveillance.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Sigma-Aldrich
甲氧苄啶, ≥98.5%
Sigma-Aldrich
四环素, 98.0-102.0% (HPLC)
Sigma-Aldrich
甲氧苄啶, ≥99.0% (HPLC)
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
红霉素, meets USP testing specifications
Supelco
甲氧苄啶, VETRANAL®, analytical standard
Supelco
环丙沙星, VETRANAL®, analytical standard
Sigma-Aldrich
红霉素, tested according to Ph. Eur.